Examples of 'antigen-presenting' in a sentence
Meaning of "antigen-presenting"
antigen-presenting (verb) - Refers to the process where specialized cells present antigens to the immune system for recognition and response. In immunology, this term is commonly used to describe the function of cells such as dendritic cells and macrophages
How to use "antigen-presenting" in a sentence
Basic
Advanced
antigen-presenting
An example of an antigen-presenting cell is a dendritic cell.
Hydroxychloroquine increases lysosomal pH in antigen-presenting cells.
The antigen-presenting cells may be transduced in vitro.
A dendritic cell is a professional antigen-presenting cell.
Preferably the antigen-presenting cells are of human origin.
Method for activation treatment of antigen-presenting cell.
Facultative antigen-presenting cells can also be used.
Dendritic cells in the mucosa are antigen-presenting cells.
Langerhans cells are antigen-presenting cells involved in epidermal immunity.
In this particular experiment, melanoma cells were used as antigen-presenting cells.
T cells are switched on by antigen-presenting cells such as dendritic cells.
In another embodiment, the phagocytic cell is a professional antigen-presenting cell.
If these cells are antigen-presenting cells, this may be particularly advantageous.
Wherein the target cell is an antigen-presenting cell.
The at least one antigen-presenting cell may be a dendritic cell.
See also
In one embodiment the exogenous promoter is an antigen-presenting cell promoter.
Paraformaldehyde-fixed antigen-presenting cells were prepared and analyzed as follows.
Dendritic cell vaccines are able to activate antigen-presenting cells directly.
Antigen-presenting capacity represents an essential aspect in setting up an adaptive immune response.
It also acts as an antigen-presenting cell.
Another therapy that is contemplated is the administration of transduced antigen-presenting cells.
In another embodiment, the antigen-presenting cell is a dendritic cell or a macrophage.
These infected cells become the secondary antigen-presenting cells.
It is preferable that the antigen-presenting cell is made herein non-proliferative.
They have to be activated by the pMHC-I complexes of antigen-presenting cells APCs.
Sometimes, the antigen-presenting cell is transduced with the nucleic acid in vivo.
Eosinophils function as antigen-presenting cells.
Antigen-presenting matrices and effector cells can be obtained from a variety of sources.
In a still further embodiment the antigen-presenting cell is a dendritic cell.
The expression of co-stimulatory molecules is a defining feature of professional antigen-presenting cells.
In some aspects the at least one antigen-presenting cell is a dendritic cell.
In a further embodiment the vector is capable of delivering the polynucleotide to an antigen-presenting cell.
More specifically, the cell is an antigen-presenting cell or an embryonic stem cell.
Preferably a sufficient amount of the antigen is used with an antigen-presenting cell.
Researchers were able to activate antigen-presenting dendritic cells in the body 's immune system.
The present invention concerns inducing and / or activating antigen-presenting cells.
Yet further, the transduced antigen-presenting cell is pulsed with tumorcell lysates.
The immune tolerance is induced by presenting autoantigens onto antigen-presenting cells.
In certain embodiments, the antigen-presenting cell is activated without the addition of an adjuvant.
In certain embodiments of the invention, macrophages and antigen-presenting cells were targeted.
Alternatively, a synthetic antigen-presenting matrix can be used to present antigen to effector cells.
The cells according to this aspect are thus advantageously antigen-presenting cells.
The transduced antigen-presenting cell is activated by administering a ligand that results in oligomerization.
Cancer vaccine comprising as an active ingredient antigen-presenting cells as disclosed herein.
An antigen-presenting cell vaccine is a vaccine made of antigens and antigen-presenting cells APCs.
Cancer vaccine comprising as an active ingredient antigen-presenting cells of the present invention.
These antigen-presenting cells can be used as the active ingredient of a tumor therapeutic agent.
These cells are recognized by macrophages or dendritic cells, which act as antigen-presenting cells.
Selection of the appropriate adjuvant to activate antigen-presenting cells to stimulate immune responses, is required.
Preferred types of malignant or neoplastic cells include any malignant antigen-presenting cell.
